Gil M. Labrucherie

2011

In 2011, Gil M. Labrucherie earned a total compensation of $1.3M as Senior Vice President and General Counsel at Nektar Therapeutics, a 11% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$306,150
Option Awards$519,759
Salary$468,083
Other$7,249
Total$1,301,241

Labrucherie received $519.8K in option awards, accounting for 40% of the total pay in 2011.

Labrucherie also received $306.2K in non-equity incentive plan, $468.1K in salary and $7.2K in other compensation.

Rankings

In 2011, Gil M. Labrucherie's compensation ranked 4,714th out of 10,747 executives tracked by ExecPay. In other words, Labrucherie earned more than 56.1% of executives.

ClassificationRankingPercentile
All
4,714
out of 10,747
56th
Division
Manufacturing
1,681
out of 3,958
58th
Major group
Chemicals And Allied Products
348
out of 1,034
66th
Industry group
Drugs
209
out of 782
73rd
Industry
Pharmaceutical Preparations
163
out of 567
71st
Source: SEC filing on April 30, 2014.

Labrucherie's colleagues

We found four more compensation records of executives who worked with Gil M. Labrucherie at Nektar Therapeutics in 2011.

2011

Howard Robin

Nektar Therapeutics

Chief Executive Officer

2011

Rinko Ghosh

Nektar Therapeutics

Senior Vice President and Chief Business Officer

2011

John Nicholson

Nektar Therapeutics

Chief Financial Officer

2011

Stephen Doberstein

Nektar Therapeutics

Chief Scientific Officer

News

You may also like